Combatting chemoresistance in GBM

Combatting chemoresistance in GBM
By using a combinational therapeutic strategy, a research team have created a promising approach to combat chemoresistance in GBM. Glioblastoma often resists front-line chemotherapies, including temozolomide, a drug that damages DNA and triggers tumour cell death. Nearly half of glioblastoma patients resist the treatment by producing a DNA-repairing enzyme, MGMT, but until recently it wasn’t clear why temozolomide wasn’t working for patients who lacked the MGMT enzyme. Using glioblast...

Comments

Popular posts from this blog

History of Escape Rooms

HSBC FUELS FILLING STATION REDEVELOPMENT IN PRESTON

ABB Formula E Race At Home Challenge Round 6: Turvey back in top ten, Ma fought his way to the front